Prior exposures to specific types of seasonal influenza viruses promote cross-reactive immunity against the H5N1 avian ...
That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback